As the survival analysis across all soft tissue sarcoma subtypes did not show a significant association between H19 expression and overall survival, focusing on larger cohorts of synovial sarcomas might uncover a significant prognostic impact of H19 expression on patient outcomes [31]. This evidence concerns the gene H19 and synovial sarcoma.